Market Cap
$3.4M
ONCO
Onconetix, Inc.
$0.7337 ▼ -1.38%
Prev close $0.7440Market cap$3.4M
High Impact Filing (8/10) Biotech & Drug Discovery
Snapshot
The big-picture read on ONCO right now — valuation, ownership and activity at a glance.
Cap Size
Nano Cap
Inst. Holders
2 funds
Inst. Value
$82.00
Insider Activity
$152.9K buy / $144.5K sell
Insider Net $
$8.4K
Social Sentiment
62° Warm
SEC Reports
17
Press Releases
5
Price chart 30d -0.7%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 reg_sho
Sep 14, 2026 SEC Reg SHO Threshold: ONCO entered the threshold list
ONCONETIX INC COM PAR $0.00001 | 5+ consecutive settlement days of fails-to-deliver ≥10k shares and
Onconetix (ONCO) entered into a Grid Promissory Note to lend Realbotix LLC up to $5.0 million, with an initial $2.5 mill
8-K — Impact 6/10
Onconetix (ONCO) entered into a Grid Promissory Note to lend Realbotix LLC up to $5.0 million, with an initial $2.5 mill
DEFA14A, 8-K — Impact 4/10
Onconetix announced a bridge financing facility of up to $5M to Realbotix, its acquisition target, with an initial $2.5M
425 — Impact 6/10
Onconetix announces a 1-for-10 reverse stock split effective May 21, 2026, to regain compliance with Nasdaq's $1 minimum
Impact 5/10
Apr 21, 2026 Insider
HRT FINANCIAL LP sold 49,710 shares
10%+ Owner @ $0.6900 ($34.3K)
Apr 20, 2026 Insider
HRT FINANCIAL LP sold 94,462 shares
10%+ Owner @ $0.7500 ($70.8K)
Apr 17, 2026 Insider
HRT FINANCIAL LP bought 34,636 shares
10%+ Owner @ $0.7300 ($25.3K)
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 13, 2023 | Maxim Group | DOWNGRADE | Hold | 43% |
| Apr 26, 2023 | HC Wainwright & Co. | MAINTAIN | Buy | 43% |
| Feb 1, 2023 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| Dec 9, 2022 | HC Wainwright & Co. | INITIATE | Buy | 43% |
| Dec 8, 2022 | Maxim Group | INITIATE | Buy | 43% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2024 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Apr 1, 2024 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Mar 1, 2024 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Feb 1, 2024 | 0 | 0 | 3 | 1 | 2 | 0% |
Social media sentiment mood -6.7%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
62°
Warm
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
17 SEC filing reports analyzed · 1 bullish, 8 bearish, 0 mixed, 8 neutral · avg impact 5.0/10.Plus 5 press releases.
BEARISH8-K6/10
Onconetix (ONCO) entered into a Grid Promissory Note to lend Realbotix LLC up to $5.0 million, with
Sep 14, 2026
NEUTRALDEFA14A, 8-K4/10
Onconetix (ONCO) entered into a Grid Promissory Note to lend Realbotix LLC up to $5.0 million, with
Sep 14, 2026
BEARISH4256/10
Onconetix announced a bridge financing facility of up to $5M to Realbotix, its acquisition target, w
Sep 14, 2026
BEARISHEFFECT8/10
Onconetix's S-1 registration (File No. 333-298259) became effective on September 3, 2026, enabling t
Sep 4, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 30, 2026
reg_sho
Reg SHO Threshold: ONCO entered the threshold list
ONCONETIX INC COM PAR $0.00001 | 5+ consecutive settlement days of fails-to-deliver ≥10k shares and ≥0.5% of shares outstanding
Sep 29, 2026
short_volume
Short Volume: ONCO — 63.9% short (2.0M / 3.2M)
Short: 2,045,402 | Exempt: 537,368 | TRF Vol: 3,199,663 | Short Ratio: 63.9% | Off-exchange volume (dark pool + OTC)
Sep 28, 2026
short_volume
Short Volume: ONCO — 55.9% short (4.2M / 7.4M)
Short: 4,160,603 | Exempt: 123,059 | TRF Vol: 7,438,818 | Short Ratio: 55.9% | Off-exchange volume (dark pool + OTC)
Sep 25, 2026
short_volume
Short Volume: ONCO — 60.8% short (16.8M / 27.7M)
Short: 16,848,128 | Exempt: 3,793,895 | TRF Vol: 27,699,492 | Short Ratio: 60.8% | Off-exchange volume (dark pool + OTC)
Sep 23, 2026
trading_halt
Halt Resumed: ONCO — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-23T19:27:04.000Z | Resumed 2026-09-23T19:32:04.000Z
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Current FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
Institutional ownership
Which big funds own ONCO (from quarterly 13F filings) and who is adding or trimming.
2 institutional holders with $82.00 total value (51,419 shares) as of 2026-Q2. Top holders: HRT, MORGAN.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| HRT FINANCIAL LP | 51,398 | $58.00 | 70.7% | — |
| MORGAN STANLEY | 21 | $24.00 | 29.3% | — |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
1 insiders, 6 transactions. Net $8.4K — $152.9K bought, $144.5K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 21, 2026 | HRT FINANCIAL LP | 10%+ Owner | SELL | 49,710 | $0.6900 | $34.3K |
| Apr 20, 2026 | HRT FINANCIAL LP | 10%+ Owner | SELL | 94,462 | $0.7500 | $70.8K |
| Apr 17, 2026 | HRT FINANCIAL LP | 10%+ Owner | BUY | 34,636 | $0.7300 | $25.3K |
| Apr 16, 2026 | HRT FINANCIAL LP | 10%+ Owner | SELL | 53,867 | $0.7300 | $39.3K |
| Apr 15, 2026 | HRT FINANCIAL LP | 10%+ Owner | BUY | 92,554 | $0.7600 | $70.3K |
| Apr 14, 2026 | HRT FINANCIAL LP | 10%+ Owner | BUY | 74,350 | $0.7700 | $57.2K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for ONCO.
Shares short
135,320
Settlement Sep 15, 2026
Change vs prior
-19.6%
Semi-monthly cycle
Days to cover
1.0
At avg daily volume
Of shares outstanding
≈3.1%
Estimate — not % of float
⚠ On the Reg SHO threshold list since Sep 30, 2026 — persistent fails-to-deliver. View list
| Halted | Code | Reason | Status |
|---|---|---|---|
| Sep 23, 2026 | LUDP | Volatility Pause | Resumed |
| Sep 23, 2026 | LUDP | Volatility Pause | Resumed |
All ONCO filing & press-release reports (22)
- 8-K reportSep 14, 2026
- DEFA14A, 8-K reportSep 14, 2026
- 425 reportSep 14, 2026
- EFFECT reportSep 4, 2026
- 425 reportSep 3, 2026
- S-1/A reportAug 31, 2026
- S-1 reportAug 12, 2026
- 8-K reportJul 29, 2026
- 425 reportJul 7, 2026
- EFFECT reportJun 17, 2026
- PRESS-RELEASE reportMay 19, 2026
- PRESS-RELEASE reportMay 13, 2026
- EFFECT reportMay 8, 2026
- S-1/A reportMay 7, 2026
- 8-K reportApr 24, 2026
- 3 reportApr 16, 2026
- PRESS-RELEASE, 425 reportApr 9, 2026
- PRESS-RELEASE, 425 reportApr 2, 2026
- 425 reportMar 31, 2026
- PRESS-RELEASE reportMar 31, 2026
- 3 reportMar 27, 2026
- PRESS-RELEASE reportMar 25, 2026